{"id":51794,"date":"2022-12-09T18:02:08","date_gmt":"2022-12-09T17:02:08","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/pfizer-declares-first-quarter-2023-dividend\/"},"modified":"2022-12-09T18:02:08","modified_gmt":"2022-12-09T17:02:08","slug":"pfizer-declares-first-quarter-2023-dividend","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/pfizer-declares-first-quarter-2023-dividend\/","title":{"rendered":"Pfizer Declares First-Quarter 2023 Dividend"},"content":{"rendered":"
\n

\nBoard of Directors approves increase in quarterly cash dividend to <\/i>$0.41 per share<\/i><\/b>\n<\/p>\n

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared an increase in the quarterly cash dividend on the company\u2019s common stock to $0.41 for the first-quarter 2023 dividend, payable March 3, 2023, to holders of the Common Stock of record at the close of business on January 27, 2023. The first-quarter 2023 cash dividend will be the 337th consecutive quarterly dividend paid by Pfizer.\n<\/p>\n

<\/a><\/p>\n

\n\u201cOur ability to increase our dividend is a testament to our solid financial performance during 2022,\u201d said Dr. Albert Bourla, Pfizer Chairman and Chief Executive Officer. \u201cThis increase reinforces Pfizer\u2019s commitment of returning value to our shareholders.\u201d\n<\/p>\n

\nAbout Pfizer: Breakthroughs That Change Patients\u2019 Lives
\n
<\/b><\/i>At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com<\/a>. In addition, to learn more, please visit us on www.Pfizer.com<\/a> and follow us on Twitter at @Pfizer<\/a> and @Pfizer News<\/a>, LinkedIn<\/a>, YouTube<\/a> and like us on Facebook at Facebook.com\/Pfizer<\/a>.\n<\/p>\n

\nCategory: Finance\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:
\n
PfizerMediaRelations@Pfizer.com<\/a>
+1 (212) 733-1226\n<\/p>\n

\nInvestor Contact:
\n
IR@Pfizer.com<\/a>
+1 (212) 733-4848\n<\/p>\n

\n\u00a0\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Board of Directors approves increase in quarterly cash dividend to $0.41 per share NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared an increase in the quarterly cash dividend on the company\u2019s common stock to $0.41 for the first-quarter 2023 dividend, payable March 3, 2023, to holders of the Common … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51794","6":"format-standard","7":"category-industry"},"yoast_head":"\nPfizer Declares First-Quarter 2023 Dividend - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/pfizer-declares-first-quarter-2023-dividend\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer Declares First-Quarter 2023 Dividend - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Board of Directors approves increase in quarterly cash dividend to $0.41 per share NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared an increase in the quarterly cash dividend on the company\u2019s common stock to $0.41 for the first-quarter 2023 dividend, payable March 3, 2023, to holders of the Common ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/pfizer-declares-first-quarter-2023-dividend\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-09T17:02:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221208006035\/en\/1045874\/21\/Pfizer_Logo_Color_RGB_APPROVED.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-first-quarter-2023-dividend\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-first-quarter-2023-dividend\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Pfizer Declares First-Quarter 2023 Dividend\",\"datePublished\":\"2022-12-09T17:02:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-first-quarter-2023-dividend\\\/\"},\"wordCount\":316,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-first-quarter-2023-dividend\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221208006035\\\/en\\\/1045874\\\/21\\\/Pfizer_Logo_Color_RGB_APPROVED.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-first-quarter-2023-dividend\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-first-quarter-2023-dividend\\\/\",\"name\":\"Pfizer Declares First-Quarter 2023 Dividend - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-first-quarter-2023-dividend\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-first-quarter-2023-dividend\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221208006035\\\/en\\\/1045874\\\/21\\\/Pfizer_Logo_Color_RGB_APPROVED.jpg\",\"datePublished\":\"2022-12-09T17:02:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-first-quarter-2023-dividend\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-first-quarter-2023-dividend\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-first-quarter-2023-dividend\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221208006035\\\/en\\\/1045874\\\/21\\\/Pfizer_Logo_Color_RGB_APPROVED.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221208006035\\\/en\\\/1045874\\\/21\\\/Pfizer_Logo_Color_RGB_APPROVED.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-first-quarter-2023-dividend\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer Declares First-Quarter 2023 Dividend\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pfizer Declares First-Quarter 2023 Dividend - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/pfizer-declares-first-quarter-2023-dividend\/","og_locale":"en_US","og_type":"article","og_title":"Pfizer Declares First-Quarter 2023 Dividend - Pharma Trend","og_description":"Board of Directors approves increase in quarterly cash dividend to $0.41 per share NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared an increase in the quarterly cash dividend on the company\u2019s common stock to $0.41 for the first-quarter 2023 dividend, payable March 3, 2023, to holders of the Common ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/pfizer-declares-first-quarter-2023-dividend\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-09T17:02:08+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221208006035\/en\/1045874\/21\/Pfizer_Logo_Color_RGB_APPROVED.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/pfizer-declares-first-quarter-2023-dividend\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/pfizer-declares-first-quarter-2023-dividend\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Pfizer Declares First-Quarter 2023 Dividend","datePublished":"2022-12-09T17:02:08+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/pfizer-declares-first-quarter-2023-dividend\/"},"wordCount":316,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/pfizer-declares-first-quarter-2023-dividend\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221208006035\/en\/1045874\/21\/Pfizer_Logo_Color_RGB_APPROVED.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/pfizer-declares-first-quarter-2023-dividend\/","url":"https:\/\/pharma-trend.com\/en\/pfizer-declares-first-quarter-2023-dividend\/","name":"Pfizer Declares First-Quarter 2023 Dividend - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/pfizer-declares-first-quarter-2023-dividend\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/pfizer-declares-first-quarter-2023-dividend\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221208006035\/en\/1045874\/21\/Pfizer_Logo_Color_RGB_APPROVED.jpg","datePublished":"2022-12-09T17:02:08+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/pfizer-declares-first-quarter-2023-dividend\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/pfizer-declares-first-quarter-2023-dividend\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/pfizer-declares-first-quarter-2023-dividend\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221208006035\/en\/1045874\/21\/Pfizer_Logo_Color_RGB_APPROVED.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221208006035\/en\/1045874\/21\/Pfizer_Logo_Color_RGB_APPROVED.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/pfizer-declares-first-quarter-2023-dividend\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Pfizer Declares First-Quarter 2023 Dividend"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51794","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51794"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51794\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51794"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51794"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51794"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}